ID

16684

Description

HuMax-CD20 in Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00093314

Link

https://clinicaltrials.gov/show/NCT00093314

Keywords

  1. 7/31/16 7/31/16 -
  2. 8/1/16 8/1/16 -
Uploaded on

August 1, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Lymphocytic Leukemia NCT00093314

Eligibility Chronic Lymphocytic Leukemia NCT00093314

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic lymphocytic leukemia
Description

Chronic Lymphocytic Leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0023434
circulating lymphocytes above a specific level
Description

Increased number of circulating lymphocytes

Data type

boolean

Alias
UMLS CUI [1]
C1849238
circulating lymphocytes showing certain markers
Description

Lymphocyte Circulating | Lymphocyte markers

Data type

boolean

Alias
UMLS CUI [1,1]
C0024264
UMLS CUI [1,2]
C0175630
UMLS CUI [2]
C0023158
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with rituximab or alemtuzumab within 6 months prior to enrollment in study.
Description

rituximab | alemtuzumab

Data type

boolean

Alias
UMLS CUI [1]
C0393022
UMLS CUI [2]
C0383429
previous stem cell transplantation.
Description

Stem cell transplant

Data type

boolean

Alias
UMLS CUI [1]
C1504389
received any of the following treatments within 4 weeks prior to entering this trial: a) anti-cancer therapy, b) glucocorticoids unless less than 10 mg per day, c) radiotherapy.
Description

cancer treatment | Glucocorticoids | Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0017710
UMLS CUI [3]
C1522449
hiv positivity.
Description

HIV Seropositivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
hepatitis b or hepatitis c.
Description

Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
other cancerous diseases, except certain skin cancers and cervix cancer.
Description

Malignant Neoplasms | Skin carcinoma | Cervix carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0699893
UMLS CUI [3]
C0302592
certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, heart, hormonal, nerve or blood diseases.
Description

medical condition Serious | Kidney Diseases | Liver diseases | Mental disorders | Stomach Diseases | Heart Diseases | Endocrine System Diseases | nervous system disorder | Hematological Disease

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0023895
UMLS CUI [4]
C0004936
UMLS CUI [5]
C0038354
UMLS CUI [6]
C0018799
UMLS CUI [7]
C0014130
UMLS CUI [8]
C0027765
UMLS CUI [9]
C0018939
participation in another trial with a different new drug 4 weeks prior to enrollment in study.
Description

Study Subject Participation Status | Investigational New Drug Different

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C1705242
current participation in any other clinical study.
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
pregnant or breast-feeding women.
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
women of childbearing age who are unable or unwilling to use adequate contraception.
Description

Childbearing Potential Age | Contraceptive methods Unwilling

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0001779
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0558080

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT00093314

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Lymphocytic Leukemia
Item
chronic lymphocytic leukemia
boolean
C0023434 (UMLS CUI [1])
Increased number of circulating lymphocytes
Item
circulating lymphocytes above a specific level
boolean
C1849238 (UMLS CUI [1])
Lymphocyte Circulating | Lymphocyte markers
Item
circulating lymphocytes showing certain markers
boolean
C0024264 (UMLS CUI [1,1])
C0175630 (UMLS CUI [1,2])
C0023158 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
rituximab | alemtuzumab
Item
previous treatment with rituximab or alemtuzumab within 6 months prior to enrollment in study.
boolean
C0393022 (UMLS CUI [1])
C0383429 (UMLS CUI [2])
Stem cell transplant
Item
previous stem cell transplantation.
boolean
C1504389 (UMLS CUI [1])
cancer treatment | Glucocorticoids | Therapeutic radiology procedure
Item
received any of the following treatments within 4 weeks prior to entering this trial: a) anti-cancer therapy, b) glucocorticoids unless less than 10 mg per day, c) radiotherapy.
boolean
C0920425 (UMLS CUI [1])
C0017710 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
HIV Seropositivity
Item
hiv positivity.
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
hepatitis b or hepatitis c.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Malignant Neoplasms | Skin carcinoma | Cervix carcinoma
Item
other cancerous diseases, except certain skin cancers and cervix cancer.
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0302592 (UMLS CUI [3])
medical condition Serious | Kidney Diseases | Liver diseases | Mental disorders | Stomach Diseases | Heart Diseases | Endocrine System Diseases | nervous system disorder | Hematological Disease
Item
certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, heart, hormonal, nerve or blood diseases.
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0004936 (UMLS CUI [4])
C0038354 (UMLS CUI [5])
C0018799 (UMLS CUI [6])
C0014130 (UMLS CUI [7])
C0027765 (UMLS CUI [8])
C0018939 (UMLS CUI [9])
Study Subject Participation Status | Investigational New Drug Different
Item
participation in another trial with a different new drug 4 weeks prior to enrollment in study.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2,1])
C1705242 (UMLS CUI [2,2])
Study Subject Participation Status
Item
current participation in any other clinical study.
boolean
C2348568 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Age | Contraceptive methods Unwilling
Item
women of childbearing age who are unable or unwilling to use adequate contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial